Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery

Neuroscience

Volumn 91, Issue 2, 1999, Pages 519-525

  Saporta, S ^a   Borlongan, C V ^a   Sanberg, P R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Behavioral recovery; Cell survival; HNT neurons; Rat; Transplantation; Xenograft

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INJURY; BRAIN ISCHEMIA; CELL SURVIVAL; CELL TRANSPLANTATION; DEGENERATIVE DISEASE; DOSE RESPONSE; FETUS; FETUS (ANATOMY); HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; TERATOCARCINOMA; XENOGRAFT;

ANIMALS; AVOIDANCE LEARNING; CELL LINE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MOTOR ACTIVITY; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TERATOCARCINOMA; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032938922     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00610-1     Document Type: Article

References (40)

1. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Devl Biol. 103:1987;285-293.
2. Bankiwicz K., Mandel R.J., Sofroniew M.V. Trophism, transplantation and animal models of Parkinson's disease. Expl Neurol. 124:1993;140-149.
3. Björklund A. Better cells for brain repair. Nature. 362:1993;414-415.
4. Björklund A., Stenevi U. Reconstruction of the nigrostriatial dopamine pathway by intracerebral nigral transplants. Brain Res. 177:1979;555-560.
5. Borlongan C.V., Cahill D.W., Sanberg P.R. Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery. Physiol. Behav. 58:1995;909-917.
6. Borlongan C.V., Koutouzis T.K., Jorden J.R., Martinez R., Rodriguez A.C., Poulous S.G., Freeman T.B., McKeown P., Cahill D.W., Nishino H., Sanberg P.R. Neural transplantation as an experimental modality for cerebral ischemia. Neurosci. Biobehav. Rev. 21:1997;79-90.
7. Borlongan C.V., Tajima Y., Trojanowski J.Q., Lee V. M.-Y., Sanberg P.R. Behavioral recovery from focal ischemia after intrastriatal transplants of human-embryonal carcinoma-derived neurons (hNT cells). Int. neural Transplant. Meeting Abstr. 6:1997;28.
8. Borlongan C.V., Tajima Y., Trojanowski J.Q., Lee V. M.-Y., Sanberg P.R. Transplantation of cyropreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Expl Neurol. 149:1998;310-321.
9. Borlongan C.V., Sanberg P.R. Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J. Neurosci. 15:1995;5372-5378.
10. Borlongan C. V., Poulos S. G., Othberg A. and Sanberg P. R. Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats. NeuroReport (in press).
11. Brundin P., Barbin G., Strecker R.E., Isacson O., Prochiantz A., Björklund A. Survival and function of dissociated rat dopamine neurons grafted at different developmental stages or after being cultured in vitro. Brain Res. 467:1988;233-243.
12. Coggeshall R.E. A consideration of neural counting methods. Trends Neurosci. 15:1992;9-13.
13. Date I., Ohmoto T., Imaoka T., Ono T., Hammang J.P., Francis J., Greco C., Emerich D.F. Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J. Neurosurg. 84:1996;1006-1012.
14. De Lay L.H., Berndsen H., Spakman H., Ter Haar A., The H. Neuroendocrine and epithelial antigens in SCLC. Lung Cancer. 4:1988;42-44.
15. Freed W.J. Neural transplantation: prospects for clinical use. Cell Transplant. 2:1993;13-31.
16. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Snow B., Vingerhoets F.J.G., Calne D., Gauger L.L. Bilateral fetal nigral transplantation into the post-commissural putamen as a treatment for Parkinson's disease: six month follow-up. Ann. Neurol. 38:1995;379-388.
17. Hammang J.P., Emerich D.F., Winn S.R., Lee A., Lindner M.D., Gentile F.T., Doherty E.J., Kordower J.H., Baetge E.E. Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases. Cell Transplant. 4(Suppl 1):1995;S27-S28.
18. Isacson O., Brundin P., Kelly P.A.T., Gage F.H., Björklund A. Functional neural replacement by grafted striatal neurons in ibotenic acid lesioned rat striatum. Nature. 311:1984;458-460.
19. Kleppner S.R., Robinson K.A., Trojanowski J.Q., Lee V. M.-Y. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J. comp. Neurol. 357:1995;618-632.
20. Koide K., Hashitani T., Aihara N., Mabe H., Nishino H. Improvement of passive avoidance task after grafting of fetal striatal cell suspensions in ischemic striatum in the rat. Restor. Neurol. Neurosci. 5:1993;205-214.
21. Koizumi J., Yoshida Y., Nakazawa T., Ooneda G. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic rats. Jap. J. Stroke. 8:1986;1-8.
22. Kordower J.H., Freeman T.B., Snow B., Vinerhoets F.J.G., Muffson E.J., Sanberg P.R., Hauser D.P., Perl D.P., Olanow C.W. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New Engl. J. Med. 332:1995;1118-1124.
23. Kurth M.C., Kopyov O.V., Dumas C.M., Jacques D.B. Six month follow-up of motor function after fetal transplantation in a patient with Huntington's disease. Am. Soc. neural Transplant. Abstr. 3:1996;15.
24. Lee V. M.-Y., Andrews W.W. Differentiation of NTERA-2 cloned human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J. Neurosci. 6:1986;333-337.
25. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leemders K.L., Sawie G., Rothewll J.C., Marsden C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;574-577.
26. Miyazono M., Nowell P.C., Finan J.L., Lee V. M.-Y., Trojanowski J.Q. Long-term integration and neuronal differentiation of human embryonal carcinoma cells (NTera-2) transplanted into the caudoputamen of nude mice. J. comp. Neurol. 376:1996;603-613.
27. Molenaar W.M., De Ley L.H., Trojanowski J.Q. Neuroectodermal tumors of the central and peripheral nervous system share neuroendocrine N-CAM-related antigens with small cell lung carcinomas. Acta neuropath. 83:1991;46-54.
28. Nishino H., Koide K., Aihara N., Kumazaki M., Sakurai T., Nagi H. Striatal grafts in the ischemic striatum improve pallidal GABA release and passive avoidance. Brain Res. Bull. 32:1993;517-520.
29. Perlow M.J., Freed W.J., Hoffer B.J., Seiger A., Olson L., Wyatt R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine systems. Science. 204:1979;643-647.
30. Pleasure S.J., Lee V. M.-Y. Ntera-2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35:1993;585-602.
31. Pleasure S.J., Page C., Lee V. M.-Y. Pure, postmitotic, polarized human neurons derived from Ntera-2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1992;1802-1815.
32. Raymon H.K., Thode S., Gage F.H. Application of ex vivo gene therapy in the treatment of Parkinson's disease. Expl Neurol. 144:1997;82-91.
33. Sanberg P.R., Borlongan C.V., Trojanowski J.Q., Lee V. M.-Y., Othberg A.I., Saporta S. Transplantation of human neuroteratocarcinoma (hNT) cells produces dose-dependent behavioral recovery in ischemic rats. Soc. Neurosci. Abstr. 23:1997;346.
34. Sanberg P.R., Lehmann J., Fibiger H.C. Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntigton's disease. Brain Res. 149:1978;546-551.
35. Sauer H., Frodl E.M., Kupsch A., ten Bruggencate G., Oertel W.H. Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Expl Brain Res. 90:1992;54-62.
36. Schinstine M., Ray J., Gage F.H. Potential effect of cytokines on transgene expression in primary fibroblasts implanted into the rat brain. Molec. Brain Res. 47:1997;195-201.
37. Trojanowski J.Q., Mantione J.R., Lee J.H., Seid D.P., You T., Inge L.J., Lee V. M.-Y. Neurons derived from a teratocarcinoma cell line establish molecular and structural polarity following transplantation into the rodent brain. Expl Neurol. 122:1993;283-294.
38. Trojanowski J.Q., Kelsten M.L., Lee V. M.-Y. Phosphate dependent and independent neurofilament epitopes are expressed throughout the cell cycle in rapidly dividing human medulloblastoma cells. Am. J. Path. 135:1989;747-758.
39. West M.J. New stereological methods for counting neurons. Neurobiol. Aging. 14:1993;275-285.
40. West M.J., Gundersen H.J.G. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. comp. Neurol. 29:1990;1-22.